Right to Try Ibogaine: What the New Federal Pathway Actually Offers — and What It Doesn’t
The new federal Right to Try pathway for ibogaine explained: who qualifies, what has to happen first, and why it
Read More
The new federal Right to Try pathway for ibogaine explained: who qualifies, what has to happen first, and why it
Read More
A new commentary in The American Journal of Psychiatry argues that ketamine’s antidepressant effects may involve a wider set of
Read More
Minnesota is moving closer to creating a regulated psilocybin therapy program, although legal access will not begin this year.
Read More
A new analysis found psilocybin dosing sessions for PTSD are silent 78 percent of the time. Why the authors want
Read More
Higher dissociation scores went with better depression outcomes on subcutaneous esketamine, with derealization driving the difference. The study was small,
Read More
Aaron Rodgers' ayahuasca experience is big for the sports world. It also opens up important conversations about psychedelic edeucation.
Read More
If you're looking for a psilocybin mushroom retreat, Andrew Tansil of Sayulita Wellness provides the keys to finding a safe
Read More
Gearing up for an epic psilocybin trip is like getting ready for a grand vacation. You gotta pack the right
Read More
MDMA treatment may have powerful psychotherapy benefits.
Read More
Standard SAMHSA 5/10-panel drug tests do NOT detect ketamine. Expanded "designer drug" panels detect ketamine for 3-5 days in urine,
Read More